Pixelworks trends higher following investments from China-based investors Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Pixelworks (PXLW) up 2% after its PWSH subsidiary entered into an agreement with a group of investors based in China, under which committed investments will be made in exchange for equity interest in PWSH and also reiterating Q4 guidance
- Generac (GNRC) up 3% after Janney Montgomery Scott analyst Sean Milligan initiated coverage with a Buy rating and $160 fair value estimate
- Tesla (TSLA) up 2% after Baird analyst Ben Kallo lowered the firm's price target on the stock to $252 from $316, but kept it on his "Best Ideas" list for 2023
- Jounce Therapeutics (JNCE) up 73% after Gilead Sciences (GILD) and the company amended their existing license agreement for GS-1811, enabling Gilead to buy out remaining contingent payments potentially due under the license agreement executed in August 2020
- Kala Pharmaceuticals (KALA) up 65% after reporting that that the FDA has accepted an investigational new drug application for the company's lead product candidate, KPI-012
- Minerva Surgical (UTRS) up 127% after entering into a share purchase agreement for the sale of 146,627,565 shares of its common stock in a private placement
LOWER -
- Southwest (LUV) down 2% as it continues to cancel flights and operate just over one-third of its typical schedule following operational challenges
Symbols:
JNCE KALA PXLW GNRC TSLA - $109.05 /
-14.09 (-11.44%)
UTRS LUV GILD Keywords: Fly Intel, Wall Street, Top Stories, Stocks